Latest filing published 05 Mar 2026 for NovoCure Ltd. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Frank X. Leonard in Novocure Ltd, where the filings describe the role as senior executive. In total, 36 filings cover trades dated from 6 July 2021 to 3 March 2026.
On the market, this insider has only sold: 23 sales, €5.1M in total. Other entries cover 12 share grants and 1 option exercise. Since January 2026: no purchases and 1 sale on the market.
The record was last updated on 5 March 2026 with a share grant in Novocure Ltd. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 36 declarations